[Fasting blood glucose has little value. Postprandial glucose indicates risk].
D001786:Blood Glucose / Q000378:metabolism*; D003510:Cyclohexanes / Q000008:administration & dosage; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000175:diagnosis*; D004359:Drug Therapy, Combination; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage; D000077715:Nateglinide; D010649:Phenylalanine / Q000008:administration & dosage / Q000031:analogs & derivatives; D019518:Postprandial Period / Q000502:physiology*; D012307:Risk Factors
D001786:Blood Glucose; D003510:Cyclohexanes; D007004:Hypoglycemic Agents; D000077715:Nateglinide; D010649:Phenylalanine
Nüchternblutzucker sagt zu wenig aus. Postprandial lauert das Risiko.